Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis

被引：0
|
作者：
Consoli, S. M.
Rolhion, S.
Martin, C.
Ruel, K.
Cambazard, F.
Pellet, J.
Misery, L.
机构：
[1] Paris 5 Univ Med, Eruopean Georges Pompidou Hosp, Dept CL Psychiat, Paris, France
[2] Univ Hosp, Dept Dermatol, St Etienne, France
[3] Univ Hosp, Dept Publ Hlth, St Etienne, France
[4] Univ Hosp, Dept Psychiat, St Etienne, France
来源：
JOURNAL OF PSYCHOSOMATIC RESEARCH | 2006年 / 61卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：423 / 424
页数：2
相关论文
共 50 条
  • [1] Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis
    Consoli, SM
    Rolhion, S
    Martin, C
    Ruel, K
    Cambazard, F
    Pellet, J
    Misery, L
    [J]. DERMATOLOGY, 2006, 212 (02) : 128 - 136
  • [2] Depression Symptoms Predict Worse Clinical Response to Etanercept Treatment in Psoriasis Patients
    Jin, Waishu
    Zhang, Shuqing
    Duan, Yanjuan
    [J]. DERMATOLOGY, 2019, 235 (01) : 55 - 64
  • [3] Low serum COMP levels predict improved response to anti-TNF treatment in patients with RA
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 (11): : 594 - 594
  • [4] Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis
    Muramatsu, Shinnosuke
    Kubo, Ryoji
    Nishida, Emi
    Morita, Akimichi
    [J]. MODERN RHEUMATOLOGY, 2017, 27 (01) : 137 - 141
  • [5] Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis
    Muramatsu, S.
    Nishida, E.
    Kubo, R.
    Shintani, Y.
    Morita, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S37 - S37
  • [6] Preliminary study of the levels of emotional awareness in depressed patients and controls
    Berthoz, S
    Ouhayoun, B
    Parage, N
    Kirzenbaum, M
    Bourgey, M
    Allilaire, JF
    [J]. ANNALES MEDICO-PSYCHOLOGIQUES, 2000, 158 (08): : 665 - 672
  • [7] Chemokine ligand 22 (CCL22) plasma levels correlate with disease severity and predict response to dithranol treatment in patients with psoriasis
    Benezeder, T. H.
    Painsi, C.
    Lange-Asschenfeldt, B.
    Hammer, K.
    Wolf, P.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S200 - S200
  • [8] LOW LEVELS OF INFLIXIMAB AT EARLY STAGES PREDICT THE LOSS OF DRUG LEVELS AND THE CLINICAL RESPONSE AT ONE YEAR OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Jurado, T.
    Plasencia, C.
    Martinez-Feito, A.
    Navarro-Compan, V.
    Olariaga, E.
    Diego, C.
    Martin-Mola, E.
    Balsa, A.
    Pascual-Salcedo, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 490 - 490
  • [9] Infliximab Low Levels at Early Stages Predict the Loss of Drug Levels and the Clinical Response at One Year of Treatment in Patients with Rheumatoid Arthritis
    Jurado, Teresa
    Plasencia-Rodriguez, Chamaida
    Martinez, Ana
    Navarro-Colmpan, Victoria
    Olariaga-Merida, Eva
    Peiteado, Diana
    Villalba, Alejandro
    Bonilla, Gema
    Diego, Cristina
    Balsa, Alejandro
    Pascual-Salcedo, Dora
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] FAILURE OF URINARY MHPG LEVELS TO PREDICT TREATMENT RESPONSE IN PATIENTS WITH UNIPOLAR DEPRESSION
    JANICAK, PG
    DAVIS, JM
    CHAN, C
    ALTMAN, E
    HEDEKER, D
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1986, 143 (11): : 1398 - 1402
12345